Immune-Onc Therapeutics, Inc. (“Immune-Onc”) is a privately held cancer immunotherapy company dedicated to the discovery and development of novel biologic treatments for cancer patients. The company aims to translate unique scientific insights in the tumor microenvironment and immune suppressive pathways to develop first-in-class biotherapeutics.

We’re excited about our mission and are committed to sharing updates on our progress.


January 25, 2018


What You Need to Know About Immune-Onc Therapeutics

An interview with Dr. Charlene Liao, CEO, President and Co-Founder, Immune-Onc Therapeutics, Inc.

January 2, 2018


Top 20 Life Science Startups to Watch in 2018

Immune-Onc Therapeutics, Inc. is named one of the Top 20 up-and-coming life science companies.


Media Contact

Tara Cooper

Cooper Communication Group